Effect of N-acetylcysteine on inflammatory markers in hemodialysis patients
Not Applicable
- Conditions
- End stage renal disease.End stage kidney disease
- Registration Number
- IRCT2015062222869N1
- Lead Sponsor
- Vice Chancellor for research of Yasuj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients aged > 18 years; patients who were dialysed at least two times per week for a 3 month period
Exclusion criteria:patients who take anti-inflammatory drugs such as steroids; patients who have active infectious disease, malignancy, kidney transplantation, rheumatic diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interleukin-6. Timepoint: 2 month. Method of measurement: ELIZA.;CRP. Timepoint: 2 month. Method of measurement: ELIZA.
- Secondary Outcome Measures
Name Time Method Drug reaction. Timepoint: 2 month. Method of measurement: Questionnaire.